STAT+: Pharmalittle: U.K. approves world’s first CRISPR-based medicine; FDA to review pricey cancer drug lacking confirmatory data
U.K. regulators approved a CRISPR-based medicine to treat sickle cell disease and beta thalassemia, ushering in a new era of genetic therapy.
Rise and shine, everyone, another busy day is on the way. We can tell because the official mascots are racing about the Pharmalot grounds and the parade of vehicles outside our window is picking up.
